PD-1/PD-L1 Control of Antigen-Specifically Activated CD4 T-Cells of Neonates

被引:6
|
作者
Majer, Christiane [1 ]
Lingel, Holger [1 ]
Arra, Aditya [1 ]
Heuft, Hans-Gert [2 ]
Bretschneider, Dirk [3 ]
Balk, Silke [1 ]
Vogel, Katrin [1 ]
Brunner-Weinzierl, Monika C. [1 ]
机构
[1] Otto von Guericke Univ, Med Fac, Dept Expt Pediat, D-39120 Magdeburg, Germany
[2] Otto von Guericke Univ, Med Fac, Inst Transfus Med & Immunohematol, D-39120 Magdeburg, Germany
[3] Hosp Sankt Marienstift, Matern Clin, D-39110 Magdeburg, Germany
关键词
T-helper cells; CD4 T cell; immune checkpoint molecule; PD-1; PD-L1; Staphylococcus aureus (S; aureus); bacteria; staphylococcus enterotoxin B (SEB); pediatric immunology; newborn; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC EXPOSURE; CTLA-4; CD152; POPULATION; EXPRESSION; CHILDREN; INFANTS; RISE;
D O I
10.3390/ijms24065662
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Newborns are highly susceptible to infections; however, the underlying mechanisms that regulate the anti-microbial T-helper cells shortly after birth remain incompletely understood. To address neonatal antigen-specific human T-cell responses against bacteria, Staphylococcus aureus (S. aureus) was used as a model pathogen and comparatively analyzed in terms of the polyclonal staphylococcal enterotoxin B (SEB) superantigen responses. Here, we report that neonatal CD4 T-cells perform activation-induced events upon S. aureus/APC-encounter including the expression of CD40L and PD-1, as well as the production of Th1 cytokines, concomitant to T-cell proliferation. The application of a multiple regression analysis revealed that the proliferation of neonatal T-helper cells was determined by sex, IL-2 receptor expression and the impact of the PD-1/PD-L1 blockade. Indeed, the treatment of S. aureus-activated neonatal T-helper cells with PD-1 and PD-L1 blocking antibodies revealed the specific regulation of the immediate neonatal T-cell responses with respect to the proliferation and frequencies of IFN gamma producers, which resembled in part the response of adults' memory T-cells. Intriguingly, the generation of multifunctional T-helper cells was regulated by the PD-1/PD-L1 axis exclusively in the neonatal CD4 T-cell lineage. Together, albeit missing memory T-cells in neonates, their unexperienced CD4 T-cells are well adapted to mount immediate and strong anti-bacterial responses that are tightly controlled by the PD-1/PD-L1 axis, thereby resembling the regulation of recalled memory T-cells of adults.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN- production via PD-1/PD-L1 blockade in bovine mycoplasmosis
    Goto, Shinya
    Konnai, Satoru
    Okagawa, Tomohiro
    Nishimori, Asami
    Maekawa, Naoya
    Gondaira, Satoshi
    Higuchi, Hidetoshi
    Koiwa, Masateru
    Tajima, Motoshi
    Kohara, Junko
    Ogasawara, Satoshi
    Kato, Yukinari
    Suzuki, Yasuhiko
    Murata, Shiro
    Ohashi, Kazuhiko
    IMMUNITY INFLAMMATION AND DISEASE, 2017, 5 (03) : 355 - 363
  • [32] PD-1 and PD-L1 prognostic in UTUC
    Stone, Louise
    NATURE REVIEWS UROLOGY, 2017, 14 (09) : 518 - 518
  • [33] PD-1 and PD-L1 prognostic in UTUC
    Louise Stone
    Nature Reviews Urology, 2017, 14 : 518 - 518
  • [34] A snapshot of the PD-1/PD-L1 pathway
    Ghosh, Chinmoy
    Luong, Gary
    Sun, Yue
    JOURNAL OF CANCER, 2021, 12 (09): : 2735 - 2746
  • [35] PD-1/PD-L1 in cardiovascular disease
    Sun, YunFeng
    Li, Liang
    Wu, YaWei
    Yang, KePing
    CLINICA CHIMICA ACTA, 2020, 505 : 26 - 30
  • [36] PD-1 and PD-L1 antibodies for melanoma
    Tsai, Katy K.
    Zarzoso, Ines
    Daud, Adil I.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3111 - 3116
  • [37] PD-1/PD-L1/CTLA-4 INHIBITOR THERAPY FOLLOWING PROGRESSION ON A DIFFERENT PD-1/PD-L1 INHIBITOR: A CASE SERIES
    Mukkamala, Suresh
    Tawagi, Karine
    Matrana, Marc
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A121 - A121
  • [38] PD-L1 binding peptide identified by phage peptide display inhibits PD-1/PD-L1 interaction and activates T cells
    Gurung, Smriti
    Khan, Fatima
    Lee, Soo-Woong
    Yoon, Jaewon
    Lee, Byungheon
    CANCER RESEARCH, 2018, 78 (13)
  • [39] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Annika De Sousa Linhares
    Claire Battin
    Sabrina Jutz
    Judith Leitner
    Christine Hafner
    Joshua Tobias
    Ursula Wiedermann
    Michael Kundi
    Gerhard J. Zlabinger
    Katharina Grabmeier-Pfistershammer
    Peter Steinberger
    Scientific Reports, 9
  • [40] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Linhares, Annika De Sousa
    Battin, Claire
    Jutz, Sabrina
    Leitner, Judith
    Hafner, Christine
    Tobias, Joshua
    Wiedermann, Ursula
    Kundi, Michael
    Zlabinger, Gerhard J.
    Grabmeier-Pfistershammer, Katharina
    Steinberger, Peter
    SCIENTIFIC REPORTS, 2019, 9 (1)